IPO Previews For The Week
Portfolio Pulse from Benzinga Insights
Amer Sports, Inc (NYSE:AS) and BIOLINGUS (CAYMAN) LIMITED (NASDAQ:SUBL) are set to go public on Feb. 1, 2024, and Jan. 31, 2024, respectively. Amer Sports will offer 100 million shares at $17.00 each, while BIOLINGUS will offer 360,000 shares at $15.50 each. Both companies have a 180-day insider lock-up period post-IPO.
January 28, 2024 | 5:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Amer Sports, Inc is set for its IPO on Feb. 1, 2024, with a price band of $16.00 to $18.00 and an offering of 100 million shares at $17.00 each.
The IPO of Amer Sports, Inc is a significant event for the company, likely to generate substantial investor interest given the size of the offering. The price band indicates a positive outlook, and the initial public interest could drive short-term price appreciation.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
BIOLINGUS (CAYMAN) LIMITED is going public on Jan. 31, 2024, with a price range of $15.00 to $16.00 and an offering of 360,000 shares at $15.50 each.
BIOLINGUS's IPO is notable due to its listing on NASDAQ and the specific price range set for the offering. The smaller number of shares compared to Amer Sports suggests a potentially higher volatility post-IPO, but also a chance for significant price movement if demand is high.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 100